Detalhe da pesquisa
1.
"Patient remodeling" as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend.
J Asthma
; 61(1): 72-75, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615543
2.
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients.
Clin Exp Allergy
; 53(1): 78-87, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490414
3.
Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab.
Allergy
; 78(12): 3154-3165, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792721
4.
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control.
J Asthma
; 60(6): 1227-1236, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282045
5.
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience.
J Asthma
; 60(1): 158-166, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112934
6.
Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experience.
Clin Exp Immunol
; 205(3): 346-353, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34061980
7.
Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?
Int J Mol Sci
; 22(7)2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33805199
8.
A gendered magnifying glass on COVID-19.
Clin Mol Allergy
; 18: 14, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32774170
9.
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
Allergy
; 76(3): 871-874, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716580
10.
Presentation and progression of MPO-ANCA interstitial lung disease.
J Transl Autoimmun
; 8: 100235, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445024
11.
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis.
Antibodies (Basel)
; 12(1)2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810518
12.
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils.
Biomedicines
; 11(3)2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36979755
13.
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.
Panminerva Med
; 65(4): 473-478, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274908
14.
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience.
Biomedicines
; 10(11)2022 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36359208
15.
Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors.
Biomedicines
; 9(10)2021 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680614
16.
Immunogenicity-unwanted immune responses to biological drugs - can we predict them?
Expert Rev Clin Pharmacol
; 14(1): 47-53, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32432941
17.
How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
Front Immunol
; 12: 765747, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34790200
18.
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis.
Sci Rep
; 11(1): 12558, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131173
19.
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer.
Gynecol Oncol Rep
; 38: 100880, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34926761
20.
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
Respir Med
; 176: 106261, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260107